Hamsters could be the best friend of a hemophiliac....BD
WASHINGTON (Reuters) Feb 21 - U.S. regulators on Thursday cleared a new drug to treat the blood-clotting disorder hemophilia made by Wyeth Pharmaceuticals.
The U.S. Food and Drug Administration said it licensed Wyeth's Xyntha anti-hemophilic factor, a genetically engineered form of factor VIII, to control and prevent bleeding in patients with hemophilia type A. The drug is made by altering genes of Chinese hamster ovary cells. The culture in which the cells are grown is free from human or animal material, nor is any added, which the FDA said minimizes the risk of infection.